CB45776-22M - 0x00000000000065F7

Males & Females of Non-Childbearing Potential

Nutshell

* Stipend may pay up to reflected amount.
Start Date: 
March 4, 2025 - 3:00pm
End Date: 
March 19, 2025 - 12:30pm

Study Details

Study Number: CB45776
Group Number: 22M
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,250.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat cancer.
Route of Administration: Oral
Blood Draws: 56

Study Schedule

Schedule Type: Long Term
Study Length: 7 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date
Friday 2/28/2025
Monday 3/3/2025
Tuesday 3/4/2025

Doctor Exam Dates:

Event Day Event Date
Friday 2/28/2025
Monday 3/3/2025
Tuesday 3/4/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 3/4/2025 3:00:00 PM Tuesday 3/11/2025 10:30:00 AM 1 Lincoln
Phone participant Wednesday 3/19/2025 12:30:00 PM 1 Lincoln